People: Novartis AG (NOVN.VX)

NOVN.VX on Virt-X Level 1

82.35CHF
29 Aug 2014
Price Change (% chg)

CHF0.35 (+0.43%)
Prev Close
CHF82.00
Open
CHF82.25
Day's High
CHF82.65
Day's Low
CHF81.85
Volume
4,008,498
Avg. Vol
3,616,052
52-wk High
CHF82.85
52-wk Low
CHF66.30

Search Stocks

Oswald, Andrin 

Brief Biography

Dr. Andrin Oswald, M.D., has been Member of the Executive Committee and Division Head of Vaccines and Diagnostics at Novartis AG since 2008. He is Permanent Attendee of the Executive Committee of Novartis AG. Before joining Novartis, Dr. Oswald was Delegate of the International Committee of the Red Cross to Nepal from 2002 to 2003 and worked with McKinsey & Company, Switzerland. In 2005, Dr. Oswald joined Novartis and advanced from Assistant to the Chairman and Chief Executive Officer (CEO), to Head of the Country Pharma Organization (CPO) and Country President for Novartis in South Korea, to CEO of Speedel and Global Head of Development Franchises at Novartis Pharma in 2008. Dr. Oswald graduated with a Doctorate in Medicine (M.D.) from the University of Geneva, Switzerland, in 1999.

Basic Compensation

Total Annual Compensation, CHF Long-Term Incentive Plans, CHF All Other, CHF Fiscal Year Total, CHF
1,095,720 1,244,300 156,652 2,496,680

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Joerg Reinhardt

1,366,320

Joseph Jimenez

13,228,200

Ulrich Lehner

853,107

Harry Kirsch

--

Peter Kornicker

--

Felix Ehrat

3,584,790
As Of 30 Dec 2012
Search Stocks